solti-1503 prometeo: t-vec atezolizumab in patients with residual bc after neoadjuvant chemo
Published 1 year ago • 99 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
3:45
barbican: ipatasertib plus atezolizumab and chemotherapy in tnbc
-
1:39
lcmc3: adjuvant and neoadjuvant atezolizumab in early-stage ncslc
-
2:03
t-cell dynamics in response to neoadjuvant atezolizumab in early nsclc
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
-
2:59
lcmc3 primary analysis: neoadjuvant atezolizumab in nsclc
-
1:43
real-world analysis of t-vec for melanoma
-
2:17
atezolizumab with adjuvant chemotherapy for early-stage triple negative breast cancer
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
36:42
evaluation of breast specimens after neoadjuvant chemotherapy
-
1:35
dr. melisko on the role of neoadjuvant chemotherapy in er cancer
-
4:48
neoadjuvant atezolizumab for non-metastatic urothelial cancer
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
11:42
pcr to neoadjuvant treatment with or without atezolizumab in early hr tnbc
-
0:53
what is neoadjuvant therapy?
-
2:33
dr. leonard gomella on neoadjuvant hormonal therapy combined with abiraterone acetate
-
0:42
embracing neo-adjuvant chemotherapy for better outcomes in triple negative breast cancer
-
3:37
sabcs 2013: neoadjuvant focus
-
3:50
breast cancer at esmo 2020: impassion131, solar-1, pallas and more
-
10:05
exploring neoadjuvant therapy for breast cancer: what you need to know